Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Kronos Bio, Inc. (KRON) had Return on Investments of -11.63% for the most recently reported fiscal quarter, ending 2023-03-31.
| Income Statement Financials | |
$1.22M |
|
$-26.24M |
|
-- |
|
$1.22M |
|
$29.71M |
|
$-28.49M |
|
$2.25M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-28.49M |
|
$-29.18M |
|
57.15M |
|
57.15M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$232.27M |
|
$12.53M |
|
$56.76M |
|
$289.02M |
|
$25.26M |
|
-- |
|
$38.16M |
|
$63.42M |
|
$225.60M |
|
$225.60M |
|
$225.60M |
|
57.35M |
|
| Cash Flow Statement Financials | |
$-5.95M |
|
$-6.36M |
|
-- |
|
$78.00M |
|
$65.70M |
|
$-12.30M |
|
$6.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2333.58% |
|
-2333.58% |
|
-- |
|
-2148.89% |
|
-2148.89% |
|
$-6.07M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-11.63% |
|
-11.63% |
|
-9.08% |
|
|
Return on Investments |
-11.63% |
$3.93 |
|
$-0.11 |
|
$-0.10 |
|